written on 15.04.2014

Generics makers ask SCOTUS to let them proceed with Copaxone copies


Teva wants generics makers to hold off on launching their copies of multiple sclerosis drug Copaxone until the Supreme Court hears its appeal in a patent fight over the drug. And unsurprisingly, those generics companies are not that into the idea.